Related references
Note: Only part of the references are listed.Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice
F. Briand et al.
DIABETES OBESITY & METABOLISM (2012)
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
A. Goncalves et al.
DIABETES OBESITY & METABOLISM (2012)
High free fatty acids level related with cardiac dysfunction in obese rats
Xiaodong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Cardioprotective Effects of Metformin and Vildagliptin in Adult Rats with Insulin Resistance Induced by a High-Fat Diet
Nattayaporn Apaijai et al.
ENDOCRINOLOGY (2012)
PPAR gamma Agonist Improves Neuronal Insulin Receptor Function in Hippocampus and Brain Mitochondria Function in Rats with Insulin Resistance Induced by Long Term High-Fat Diets
Noppamas Pipatpiboon et al.
ENDOCRINOLOGY (2012)
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice
Sirinart Kumfu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
A. D. Dobrian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria
Dawn K. Coletta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
Meimei Yin et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
A. J. Tremblay et al.
DIABETES OBESITY & METABOLISM (2011)
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats
Brian Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Effects of DPP-4 inhibition on cardiac metabolism and function in mice
M. Lenski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria
Savitree Thummasorn et al.
MITOCHONDRION (2011)
Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone
Wasana Pratchayasakul et al.
LIFE SCIENCES (2011)
Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis
Takanori Matsui et al.
PHARMACOLOGICAL RESEARCH (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease
Philip A. Read et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2010)
Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats
Anchalee Pongchaidecha et al.
NUTRITION (2009)
Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure-Prone Rat
Indu Poornima et al.
CIRCULATION-HEART FAILURE (2008)
Phosphoethanolamine-complexed C-reactive protein:: A pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum
Sanjay K. Singh et al.
CLINICA CHIMICA ACTA (2008)
Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction
Edward W. Kraegen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice
Grace Flock et al.
DIABETES (2007)
Heart rate variability in thalassemic mice
Tanat Incharoen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Heart rate variability in myocardial infarction and heart failure
Nipon Chattipakorn et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Metallothionein prevents high-fat diet-induced cardiac contractile dysfunction -: Role of peroxisome proliferator-activated receptor γ coactivator 1α and mitochondrial biogenesis
Feng Dong et al.
DIABETES (2007)
The role of vildagliptin in the management of type 2 diabetes mellitus
Erika L. Kleppinger et al.
ANNALS OF PHARMACOTHERAPY (2007)
Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats
BF Burkey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes
A Mari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
DM Ouwens et al.
DIABETOLOGIA (2005)
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
AK Bose et al.
DIABETES (2005)
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
B Ahrén et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Share Paper
